Close Menu

NEW YORK (360Dx) – Australian proteomics firm Proteomics International Laboratories said today it has licensed its PromarkerD test for diabetic kidney disease to Patia BioPharma for commercialization in Mexico.

According to Proteomics International, Patia will develop and commercialize PromarkerD as a mass spec-based laboratory-developed test performed by its partner, Clinica Ruiz Laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.